Recombinant fusion peptides containing single or multiple repeats of a ubiquitous T-helper epitope are highly immunogenic

Molecular Immunology

Volumn 33, Issue 13, 1996, Pages 1017-1024

  Astori, Mireille ^a   Kraehenbuhl, Jean Pierre ^a,b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

Fusion protein; Immunogenicity; MMTV; Superantigen; Tetanus toxin; Vaccination

Indexed keywords

EPITOPE; HYBRID PROTEIN; SUPERANTIGEN; TETANUS TOXIN; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; FEMALE; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIGENS, VIRAL, TUMOR; EPITOPES; FEMALE; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; SUPERANTIGENS; T-LYMPHOCYTES, HELPER-INDUCER; TETANUS TOXIN; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0030236076     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(96)00068-5     Document Type: Article

References (32)

1. Acha-Orbea H., Scarpellino L., Shakhov A. N., Held W. and MacDonald H. R. (1992) Inhibition of mouse mammary tumor virus-induced T-cell responses in vivo by antibodies to open reading frame protein. J. exp. Med. 176, 1769-1772.
2. Acha-Orbea H., Shakhov A. N., Scarpellino L., Kolb E., Müller V., Vessaz-Shaw A., Fuchs R., Blochlinger K., Rollini P., Billotte J., Sarafidou M., MacDonald H. R. and Diggelmann H. (1991) Clonal deletion of V beta 14 positive T cells in mammary tumor virus transgenic mice. Nature 350, 207-211.
3. Astori M., Acha-Orbea H. and Kraehenbuhl J. P. Immunization against a mouse mammary tumor virus envelope epitope prevents tumor formation but not chronic infection (submitted to J. Virology).
4. Babbit B. P., Allen P. M., Matsueda G., Haber E. and Unanue E. R. (1985) Binding of immunogenetic peptides to Ia histocompatibility molecules. Nature 317, 359-363.
5. Bennett B., Check I. J., Olsen M. R. and Hunter R. L. (1992) A comparison of commercially available adjuvants for use in research. J. Immun. Meth. 153, 31-40.
6. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Choi Y., Kappler W. and Marrack P. (1991) A superantigen encoded in the open reading frame of the 3′ long terminal repeat of mouse mammary tumor virus. Nature 350, 203-207.
8. Corradin G., Etlinger H. M. and Chiller J. M. (1977) Lymphocyte specificity to protein antigens. i. characterization of the antigen-induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice. J. Immun. 119, 1048-1053.
9. Cox J. H., Ivanyi J., Young D. B., Lamb J. R., Syred A. D. and Francis M. J. (1988) Orientation of epitopes influences the immunogenicity of synthetic peptide dinners. Eur. J. Immun. 18, 2015-2019.
10. Demotz S., Lanzavecchia A., Eisel U., Niemann H., Widmann C. and Corradin G. (1988) Delineation of several dr-restricted and tetanus toxin-specific human T-cell clones. J. Immun. 142, 394-402.
11. Dion A. S., Knittel J. J. and Morneweck S. T. (1990) Virus envelope-based peptide vaccines against virus-induced mammary tumors. Virology 179, 474-477.
12. Eflinger H. M., Felex A. J., Gillessen D., Heimer E. P., Just M., Pink J. R., Sinigaglia F., Strehler D., Tukacs B., Trzecink A. and Matile H. (1988) Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J. Immun. 140, 626-633.
13. Francis M. J., Hastings G. Z., Syred A. D., McGinn B., Brown F. and Rowlands D. J. (1987) Non-responsiveness to a foot- and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 300, 168-170.
14. Golovkina T. V., Chervonsky A., Dudley J. P. and Ross S. R. (1992) Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell 69, 637-646.
15. Golvano J., Lasarte J. J., Sarobe P., Gullon A., Prieto J. and Borras-Cuesta F. (1990) Polarity of immunogens: implications for vaccine design. Eur. J. Immun. 20, 2363-2366.
16. Good M. F., Maloy W. L., Lunde M. N., Margalit H., Cornette J. L., Smith G. L., Moss B., Miller L. H. and Berzofsky J. A. (1987) Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science 235, 1059-1062.
17. Grillot D., Valmori D., Lambert P. H., Corradin G. and Del Giudice G. (1993) Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes. Infect. Immun. 61, 3064-3067.
18. Held W., Waanders G. A., Shakhov A. N., Scarpellino L., Acha-Orbea H. and MacDonald H. R. (1993) Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell 74, 529-540.
19. Hochuli E., Bannwarth W., Döbeli H., Gentz R. and Stüber D. (1988) Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent. Biotechnology 6, 1321-1325.
20. Hopkins S., Kraehenbuhl J. P., Schödel F., Potts A., Peterson D., De Grandi P. and Nardelli-Haefliger D. (1995) A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect. Immun. 63, 3279-3286.
21. Leclerc C., Przewlocki G., Schutze M. P. and Chedid L. (1987) A synthetic vaccine constructed by copolymerization of B and T cell determinants. Eur. J. Immun. 17, 269-273.
22. Löwenadler B., Svennerholm A. M., Gidlund M., Holmgren E., Krook K., Svanholm C., Ulff S. and Josephson S. (1990) Enhanced immunogenicity of recombinant peptide fusions containing multiple copies of a heterologous T-helper epitope. Eur. J. Immun. 20, 1541-1545.
23. Milich D. R., Hughes J. L., McLachlan A., Thornton G. B. and Moriarty A. (1988) Hepatitis b synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc. natn. Acad. Sci. U.S.A. 85, 1610-1614.
24. Panina-Bordignon P., Tan A., Termitjelen A., Demotz S., Corradin G. and Lanzavecchia A. (1989) Universally immunogenic T-cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immun. 19, 2237-2242.
25. Rosenberg A. H., Lade B. N., Chui D. S., Lin S. W., Dunn J. J. and Studier F. W. (1987) Vectors for selective expression of cloned DNAs by t7 RNA polymerase. Gene 56, 125-135.
26. Schagger H. and Jagow G. von (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal. Biochem. 199, 223-231.
27. Sinigaglia F., Guttinger M., Kilgus J., Doran D. M., Matile H., Etlinger H., Trzeciak A., Gillessen D. and Pink J. R. (1988) A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature 336, 778-780.
28. Smith D. B. and Johnson K. S. (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
29. Snippe H., De Reuver M. J., Strickland F., Willers J. M. and Hunter R. L. (1981) Adjuvant effect of nonionic block polymer surfactants in humoral and cellular immunity. Intl Arch. Allerg. appl. Immun. 65, 390-398.
30. Tam J. P. and Lu Y. (1988) Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-epitopes. Proc. natn. Acad. Sci. U.S.A. 86, 9084-9088.
31. Valmori D., Pessi A., Bianchi E. and Corradin G. (1992) Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immun. 149, 717-721.
32. Widmann C., Romero P., Maryanski J. L., Corradin G. and Valmori D. (1992) T-helper epitopes enhance the cytotoxic response of mice immunized with MHC class 1-restricted malaria peptides. J. Immun. Meth. 155, 95-99.